Effects of alprazolam and diazepam on the daytime sleepiness of non-anxious subjects
- PMID: 3931145
- DOI: 10.1007/BF00431806
Effects of alprazolam and diazepam on the daytime sleepiness of non-anxious subjects
Abstract
Eighteen non-anxious volunteers underwent sleep recordings and daytime tests of sleepiness, performance, and mood while receiving, either alprazolam 0.5 mg b.i.d. or diazepam 5 mg b.i.d. for 7 consecutive days. Recordings and tests were done before treatment and on the 1st and 7th days of treatment. Nocturnal sleep changes were similar for both groups; there were no statistically significant changes in mood. However, levels of daytime sleepiness differed. Alprazolam subjects showed more daytime sedation than diazepam subjects on treatment day 1, but showed a significant decrease in Day 1-7 daytime sedation. Although diazepam subjects were less sedated at the onset, they showed no tolerance to this effect; thus by treatment day 7, the two groups did not differ in levels of daytime sleepiness. Results suggested that tolerance to alprazolam's sedative effects (which develops during the 1st week of treatment) may be separable from tolerance to its antianxiety effects (which develops after at least 4 weeks). As daytime sedation is common and potentially dangerous with most anxiolytics, selective tolerance to this side effect is highly desirable.
Similar articles
-
Daytime sleepiness, performance, mood, nocturnal sleep: the effect of benzodiazepine and caffeine on their relationship.Sleep. 1990 Apr;13(2):121-35. doi: 10.1093/sleep/13.2.121. Sleep. 1990. PMID: 2184488 Clinical Trial.
-
A dose response study of the hypnotic effectiveness of alprazolam and diazepam in normal subjects.Psychopharmacology (Berl). 1981;75(3):258-61. doi: 10.1007/BF00432435. Psychopharmacology (Berl). 1981. PMID: 6798616 Clinical Trial.
-
The effects of alprazolam, quazepam and diazepam on saccadic eye movements, parameters of psychomotor function and the EEG.Fundam Clin Pharmacol. 1990;4(6):653-61. doi: 10.1111/j.1472-8206.1990.tb00045.x. Fundam Clin Pharmacol. 1990. PMID: 1982881 Clinical Trial.
-
Psychomotor effects of alprazolam and diazepam during acute and subacute treatment, and during the follow-up phase.Acta Pharmacol Toxicol (Copenh). 1985 May;56(5):364-72. doi: 10.1111/j.1600-0773.1985.tb01305.x. Acta Pharmacol Toxicol (Copenh). 1985. PMID: 2863920 Clinical Trial.
-
Comparative study of the abuse liability of alprazolam, lorazepam, diazepam, methaqualone, and placebo.Int J Addict. 1988 May;23(5):449-67. doi: 10.3109/10826088809039211. Int J Addict. 1988. PMID: 3061941 Review.
Cited by
-
Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone.Eur J Clin Pharmacol. 2003 Dec;59(10):761-6. doi: 10.1007/s00228-003-0674-3. Epub 2003 Oct 18. Eur J Clin Pharmacol. 2003. PMID: 14566442 Clinical Trial.
-
Effects of 1 week administration of two benzodiazepines on the sleep and early daytime performance of normal subjects.Psychopharmacology (Berl). 1989;99(1):91-3. doi: 10.1007/BF00634459. Psychopharmacology (Berl). 1989. PMID: 2506608 Clinical Trial.
-
Drug treatment of patients with insomnia and excessive daytime sleepiness: pharmacokinetic considerations.Clin Pharmacokinet. 1999 Oct;37(4):305-30. doi: 10.2165/00003088-199937040-00003. Clin Pharmacokinet. 1999. PMID: 10554047 Review.
-
Benzodiazepines and vigilance performance: a review.Psychopharmacology (Berl). 1989;98(2):145-56. doi: 10.1007/BF00444684. Psychopharmacology (Berl). 1989. PMID: 2569213 Review.
-
Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation.PLoS One. 2016 Sep 7;11(9):e0162452. doi: 10.1371/journal.pone.0162452. eCollection 2016. PLoS One. 2016. PMID: 27603791 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials